DOBRINA, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 6.109
EU - Europa 2.478
AS - Asia 2.436
SA - Sud America 313
AF - Africa 101
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.451
Nazione #
US - Stati Uniti d'America 6.049
SG - Singapore 847
PL - Polonia 662
CN - Cina 647
UA - Ucraina 440
IT - Italia 304
SE - Svezia 299
HK - Hong Kong 271
BR - Brasile 252
VN - Vietnam 220
FI - Finlandia 151
FR - Francia 126
KR - Corea 123
GB - Regno Unito 109
DE - Germania 87
RU - Federazione Russa 87
TR - Turchia 87
BD - Bangladesh 84
MA - Marocco 74
BG - Bulgaria 68
IE - Irlanda 68
IN - India 39
CA - Canada 26
JP - Giappone 19
MX - Messico 19
CH - Svizzera 18
AR - Argentina 17
NL - Olanda 15
IQ - Iraq 14
SA - Arabia Saudita 14
BE - Belgio 13
EC - Ecuador 13
ZA - Sudafrica 11
ID - Indonesia 10
AU - Australia 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
VE - Venezuela 8
PH - Filippine 7
PK - Pakistan 6
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
KZ - Kazakistan 5
MY - Malesia 5
RO - Romania 5
ES - Italia 4
AT - Austria 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
GR - Grecia 3
KE - Kenya 3
LT - Lituania 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
HN - Honduras 2
JO - Giordania 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MG - Madagascar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.451
Città #
Woodbridge 717
Fairfield 603
Warsaw 591
Ashburn 553
Singapore 506
Ann Arbor 485
Houston 449
Jacksonville 386
Wilmington 334
Chandler 308
San Jose 270
Hong Kong 266
Seattle 262
Cambridge 218
Hefei 156
Princeton 132
Beijing 126
Seoul 121
Boardman 107
Chicago 89
Izmir 82
Santa Clara 82
Casablanca 69
Dublin 68
Sofia 68
Zgierz 66
Columbus 64
Ho Chi Minh City 63
Trieste 60
Lauterbourg 59
Hanoi 58
Milan 58
Los Angeles 57
Buffalo 49
Moscow 43
Dearborn 35
Dallas 32
Frankfurt am Main 32
The Dalles 29
San Diego 28
São Paulo 24
Falls Church 21
Munich 21
Düsseldorf 20
Jinan 18
New York 18
Nanjing 17
London 16
Washington 16
Des Moines 14
Phoenix 14
Brussels 13
Guangzhou 13
Turku 13
Bern 12
Tokyo 12
Verona 12
Council Bluffs 11
Shenyang 11
Tianjin 11
Helsinki 10
Norwalk 10
Brooklyn 9
Jersey City 9
Kunming 9
Miano 9
Orem 9
Da Nang 8
Denver 8
Hebei 8
Montreal 8
Shanghai 8
Atlanta 7
Belo Horizonte 7
Nanchang 7
Quito 7
Rome 7
Shenzhen 7
Toronto 7
Auburn Hills 6
Dong Ket 6
Haiphong 6
Hangzhou 6
Johannesburg 6
Long Branch 6
Paris 6
Rio de Janeiro 6
Stockholm 6
Campinas 5
Fuzhou 5
Indiana 5
Nuremberg 5
Poplar 5
Portsmouth 5
Salvador 5
San Francisco 5
Secaucus 5
Tappahannock 5
Amsterdam 4
Brasília 4
Totale 8.354
Nome #
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 434
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. 416
Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. 399
Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. 250
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation. 241
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction. 236
Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase 223
Widespread myocardial inflammation and infarct-related artery patency. 214
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 214
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 213
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction 212
Disorders of neutrophil functions 201
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 200
Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. 199
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 197
Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction. 193
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 192
Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. 186
Apoptosis and post-infarction left ventricular remodeling. 186
Complement-endothelial cell interactions: pathophysiological implications. 184
Effect of acylated flavonoids on neutrophil adherence to endothelial cells. 183
High-risk clinical features predict increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery. 180
Soluble interleukin-2 receptor: is there a role in ischaemic cardiomyopathy? 178
Complement-endothelial cell interactions: pathophysiological implications. 177
Heterogeneity of macrophages as revealed by studies on their oxidative metabolism 172
Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation. 171
Inhibition of neutrophil adherence to vascular endothelial cells a new acylated flavonoid. 169
Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance 164
Cirrhotic cardiomyopathy. 162
Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. 160
New therapeutic approaches to liver fibrosis: a practicable route? 158
Prostacyclin in sepsis: a systematic review. 156
Effects of acylated flavonoids on neutrophil adherence to endothelial cells 155
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 154
Multiple receptors on human monocytes are involved in adhesion to cultured human endothelial cells. 153
Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy. 153
Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. 151
CD11/CD18-independent neutrophil adherence to inducible endothelial-leucocyte adhesion molecules (E-LAM) in vitro. 151
Iloprost: an adjunctive approach to chronic viral hepatitis treatment. 148
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention. 147
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. 142
Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. 137
Metabolic properties of freshly isolated bovine endothelial cells. 136
Prostacyclin in liver disease: a potential therapeutic option. 135
Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes 135
Complement-endothelial cell interaction: pathophysiological implications. 133
Enhanced portal flow velocity and volume following Iloprost treatment 133
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. 132
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications. 130
The respiratory burst and endothelial cells 130
Identification and partial characterization of a cytolytic toxin produced by Gardnerella vaginalis. 129
Phorbol ester causes down-regulation of CD11/CD18-independent neutrophil adherence to endothelium. 127
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis. 125
Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor alpha from human monocytes. 120
Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting. 120
Biological activity of a peptidoglycan extracted from Leptospira interrogans: in vitro studies. 116
Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome. 115
null 108
Isolation of metabolically active endothelial cells in high yield from bovine cavernous bodies. A model for functional studies on freshly isolated microvascular endothelial cells. 108
[Mediastinal lymphangioma (with a report on 3 personal cases)]. 106
null 101
null 101
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. 97
null 96
Inhibition of netrophil adherence to vascular endothelial cells by a new acylated flavonoid. 92
Leptospira icterohemorrhagiae and leptospire peptidoglycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes 85
null 80
Neutrophil-endothelial cell interaction:evidence for and mechanisms of bovine microvascular endothelial cells self protection from hydrogen peroxide-induced oxidative stress 79
TUMOR NECROSIS FACTOR-ALPHA EXHIBITS GREATER PROINFLAMMATORY ACTIVITY THAN LYMPHOTOXIN IN VITRO. 77
null 67
High-Risk clinical increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery 66
null 64
null 61
Mechanisms of eosinophil adherence to cultured vascular endothelial cell. Eosinophils bind to the cytokine-induced endothelial ligand Vascular Cell Adhesion Molecule-1 via the Very Late Activation antigen-4 integrin receptor. 56
null 48
Totale 11.719
Categoria #
all - tutte 33.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022737 30 41 26 51 12 61 24 32 83 70 81 226
2022/2023916 81 85 62 138 95 171 17 55 156 2 40 14
2023/2024532 38 31 27 27 62 67 99 97 5 11 29 39
2024/20251.004 18 16 54 83 169 89 89 59 103 108 92 124
2025/20263.029 146 193 244 375 247 282 438 104 288 426 147 139
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 11.719